|
67
|
216
|
5le5M |
Native human 20s proteasome at 1.8 angstrom |
|
65
|
244
|
5le5G |
Native human 20s proteasome at 1.8 angstrom |
|
58
|
202
|
5lf6N |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
67
|
239
|
5leyF |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
213
|
5lf0L |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
69
|
213
|
5lf7L |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
63
|
234
|
5lexE |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
59
|
202
|
5lf1N |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
63
|
244
|
5lf0G |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
54
|
196
|
5lf0J |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
60
|
234
|
5lf7E |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
54
|
196
|
5lf1J |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
63
|
233
|
5lf7D |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
70
|
239
|
5lf4F |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
61
|
220
|
5lf1H |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
62
|
244
|
5lf1G |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
67
|
216
|
5lf4M |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
54
|
196
|
5lezJ |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
53
|
204
|
5lf6I |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
65
|
230
|
5lf3A |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
53
|
204
|
5lf0I |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
61
|
234
|
5leyE |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
244
|
5lf4G |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
65
|
230
|
5lf7A |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
62
|
220
|
5lexH |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
61
|
220
|
5lf7H |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
54
|
196
|
5lf6J |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
69
|
239
|
5lf6F |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
68
|
213
|
5lf4L |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
64
|
244
|
5leyG |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
233
|
5leyD |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
237
|
5leyC |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
66
|
216
|
5lf3M |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
74
|
248
|
5lexB |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
67
|
200
|
5leyK |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
67
|
239
|
5lf1F |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
54
|
196
|
5lf3J |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
64
|
239
|
5lf0F |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
70
|
240
|
5l62C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
244
|
5l65B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
59
|
226
|
5l5wH |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
60
|
222
|
5l60L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
64
|
211
|
5l64K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
243
|
5l60F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
57
|
195
|
5l62J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
64
|
241
|
5l65G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
204
|
5l65I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
63
|
222
|
5l5wL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
71
|
243
|
5l64F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
226
|
5l60H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
